Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Double Dummy, Phase IV, Randomized, Multicenter, Parallel Group, Placebo Controlled Trial to Evaluate the Effect of Rosuvastatin on Triglycerides Levels in Mexican Hypertriglyceridemic Patients

NCT00473655 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00473655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00473655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Double Dummy, Phase IV, Randomized, Multicenter, Parallel Group, Placebo Controlled Trial to Evaluate the Effect of Rosuvastatin on Triglycerides Levels in Mexican Hypertriglyceridemic Patients
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2007
Completion date
February 28, 2009
Enrollment
334 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia, hyperlipoproteinemia type iib, hyperlipoproteinemia type iv, hyperlipoproteinemia type v, hypertriglyceridemia